Mirae Asset Global Etfs Holdings Ltd. Bio Atla, Inc. Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $39.6 Billion
- Q2 2024
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Bio Atla, Inc. stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 22,778 shares of BCAB stock, worth $47,833. This represents 0.0% of its overall portfolio holdings.
Number of Shares
22,778Holding current value
$47,833% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding BCAB
# of Institutions
83Shares Held
22.1MCall Options Held
10.7KPut Options Held
7.4K-
Soleus Capital Management, L.P. Greenwich, CT3.9MShares$8.19 Million0.54% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.89MShares$3.96 Million0.0% of portfolio
-
Morgan Stanley New York, NY1.85MShares$3.9 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny1.65MShares$3.46 Million0.0% of portfolio
-
Tang Capital Management LLC San Diego, CA1.37MShares$2.89 Million0.23% of portfolio
About BioAtla, Inc.
- Ticker BCAB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,304,100
- Market Cap $76.2M
- Description
- BioAtla, Inc., a clinical stage biopharmaceutical company, develops specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Its lead product candidate is BA3011, a conditionally active biologic (CAB) antibody-drug conjugate (ADC) for soft tissue and bone sarcoma tumors, non-small cell lung cancer (NSCLC), and ...